Skip to content

Harrow HROW Debt-to-equity

Debt-to-equity at other companies

AbbVie logo
AbbVieABBV
46.6×+38.6×
Bausch + Lomb logo
Bausch + LombBLCO
0.8×0.0×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
0.1×-0.2×
Viatris logo
ViatrisVTRS
+0.1×
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
0.3×0.0×
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
0.5×-0.1×

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Current ratio2.5×+1.6×

Where this comes from

Calculated from Harrow’s reported figures.

Based on the most recent quarter.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's debt-to-equity?
Harrow (HROW) reported debt-to-equity of 10.7× in Q1 2026.
How has Harrow's debt-to-equity changed year-over-year?
Harrow's debt-to-equity increased by 31.9% year-over-year, from 8.1× to 10.7×.
What is the long-term trend for Harrow's debt-to-equity?
Over 5 years (2020 to 2025), Harrow's debt-to-equity has grown at a 37.5% compound annual growth rate (CAGR), from 1× to 4.9×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.